Country of Origin: UK Manufacturer/Importer/Packed By: Perricone
Follow any personalized aftercare advice provided by your dermatologist
Check your "Action Center" for a notification
Releasing Q2 earnings on Monday, Hims & Hers Co-Founder and CEO Andrew Dudem said users of its personalized GLP-1 treatment plans had lost an average 10.3% of their body weight over six months, and that only 25% of them had discontinued treatment, particularly encouraging when considering discontinuation rates in certain publicly available studies reached approximately 80% percent by six months. Saying that personalized treatments allow patients to receive clear treatment instructions and educational content while also accessing tools such as water intake trackers and calorie counters, Dudem complained of pushback from traditional incumbents. During its own earnings call on Wednesday, Novo Nordisk doubled down against GLP-1 compounders that it says are still around despite the end of an FDA-granted grace period in May
Our experienced medical providers will work closely with you to determine whether skinny shots are right for your health goals and to discuss all associated costs upfront
Tania Dempsey: Well, there's people like, you know, Mark Pimentel and whatever, there are lots of people who are, you know, suggesting that, you know, we need, you know, I don't know, statin drugs to help prevent archaea from